June Newsmakers Including ASCO Coverage

June 7, 2019
By: Julie Poucher Harbin, Writer, DCI

ASCO 2019 Coverage

Duke Cancer Institute Team Photo at ASCO 2019What's Happening at ASCO 2019? (Medscape)
Features Yousuf Zafar, MD, MA

LISTEN: High Deductibles Push Millions Of Americans To Make 'Difficult Sacrifices' For Health Care (WBUR)
Features Yousuf Zafar, MD, MA

Soaring insurance deductibles and high drug prices hit sick Americans with a ‘double whammy’ (Los Angeles Times)
Features Yousuf Zafar, MD, MA

WATCH: The Quality and Completeness of Data (Oncology Tube)
Features Yousuf Zafar, MD, MA

ACA Medicaid Expansion Reduces Disparities in Cancer Care (Medscape)
Features Yousuf Zafar, MD, MA

Medicaid Expansion Eliminated Racial Disparities in Timeliness of Treatment Between Black and White Patients With Advanced Cancer (Cancer Therapy Advisor)
Features Yousuf Zafar, MD, MA

ASCO 2019: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors (University of Colorado Anschutz Medical Campus)
Features Thomas Stinchcombe, MD

Brigatinib Shows Activity Following Other ALK TKIs in ALK+ NSCLC (Targeted Oncology)
Thomas Stinchcombe, MD

GU oncologists Tian Zhang, MD, and Daniel George, MD, at ASCO 2019 Poster SessionNIH Precision Medicine Trial Releases Cancer Study Results (Health IT Analytics & Medical Express)
Features April Salama, MD

ASCO Poster Rounds: Provenge Benefits Black Prostate Ca Patients Most (Medpage Today)
Alexandra Mara, MD, and Susan Halabi, PhD

WATCH: Dr. Daniel George on the Treatment Landscape for RCC (Cancer Network)
Features Daniel George, MD

WATCH: S-TRAC Study Data: Took 3 Years To Complete, Disease Free Survival Rate Improved By 24With 1 Year Of Adjuvant Sunitinib (Oncology Tube)
Features Daniel George, MD

WATCH: Tian Zhang, MD, shares thoughts on the PDIGREE trial in metastatic, untreated RCC (OBR)

Breast oncologist Cary Anders, MD, being interviewed at ASCO 2019ASCO 2019: ARCHES: Efficacy of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-sensitive Prostate Cancer (Uro Today)
Features Andrew Armstrong, MD

ASCO 2019: Enzalutamide versus Enzalutamide, Abiraterone, and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Alliance A031201(Uro Today)
Features Andrew Armstrong, MD, and Susan Halabi, PhD

ASCO 2019: Overall Survival of African-American and Caucasian Men Who Received Sipuleucel-T for Metastatic Castration-resistant Prostate Cancer: Final PROCEED Analysis (Uro Today)
Features Andrew Armstrong, MD

Abemaciclib stabilizes brain metastases in breast cancer subtype (Healio)
Features Cary Anders, MD

Improving Response to Front-Line Therapy in Advanced Ovarian Cancer (MedPage Today)
References Angeles Alvarez Secord, MD

More In the News

Opinion | People with chronic illness are not problems to be solved. We’re people to be loved. (The Washington Post)
Features Kate Bowler, PhD

Dreading a Colonoscopy? Other Tests Are Just as Effective for Colon Cancer (Healthline)
Features Deborah Fisher, MD, MHS

The cost of cancer: 25% of survivors face financial hardship, report finds (CNN)
Features Rachel Greenup, MD

Cancer patients, survivors 'rejuvenated' at Duke Survivorship Day (WTVD)

Durham woman spreads hope while living with pancreatic cancer (WRAL)
Features DCI patient and Kevin Shah, MD

A Shortage Of End-Of-Life Doctors Is Coming (Forbes)
Features Arif Kamal, MD

Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer (Uro Today)
Features Brant Inman, MD; Yingqi Wang, BS; Andrew Chang, MD; Wei Phin Tan, MD; Joseph J Fantony, MD; Ajay Gopalakrishna, BS; Gregory J Barton, MD; Paul E Wischmeyer, MD; Rajan T Gupta, MD

How prostate cancer cells mimic bone when they metastasize (Science Daily)
Features Andrew Armstrong, MD

Report: Role of Surgery Limited in Advanced Pancreatic Ductal Adenocarcinoma (Clinical Oncology News)
Features Peter Allen, MD

Second Annual Victory Ride to Cure Cancer Raises More Than $230,000 for Cancer Research (Oncology Nursing News)
Features Duke Cancer Institute

Myeloma Treatment Landscape Continues to Change (Oncology Nursing News)
Features Cristina Gasparetto, MD

Encouraging Trend: New Evidence Says Rates Of Cancer Deaths Are On The Decline (Survivor.Net)
Features Michael Kastan, MD, PhD

Combination Therapies Offer Newer Options for CLL Treatment (Cure)
Features Danielle Brander, MD

WATCH: Dr. Clarke Compares TKIs in EGFR+ NSCLC (OncLive)
Features Jeffrey M. Clarke, MD

WATCH: Dr. Stinchcombe on the Benefit of Alectinib in ALK+ NSCLC (OncLive)
Features Thomas Stinchcombe, MD

WATCH: Dr. Ready on the Benefit of PD-L1 Inhibition in SCLC (OncLive)
Features Neal Ready, MD

LISTEN: Gaining Ground in GI Cancers in Durham (OncLive)
Features John Strickler, MD; Niharika Mettu, MD; and Michael Morse, MD

Navigating Between High- and Low-Intensity Treatment Options in AML (OncLive)
Thomas W. LeBlanc, MD

Navigating the Complex Treatment Paradigm of Relapsed/Refractory Multiple Myeloma (OncLive)
Features Q & A with Cristina Gasparetto, MD

Pipeline Updates Advance Paradigms Across Lymphomas (OncLive)
Features Matthew McKinney, MD

WATCH: Dr. McKinney Discusses the Watch-and-Wait Approach in MCL (OncLive)
Features Matthew McKinney, MD

Expert Excited for Next Steps With CAR-T in Non-Hodgkin Lymphoma (OncLive)
Features Ahmed Galal, MD

WATCH: Dr. Kang on the Preclinical Activity of ABC294640 in Multiple Myeloma (OncLive)
Features Yubin Kang, MD

Novel Triplets, Potent Single Agents Emerge Across Myeloma Spectrum (OncLive)
Features Yubin Kang, MD

TKI Discontinuation Still an Unclear Picture in CML (OncLive)
Features Lindsay Rein, MD

WATCH: Dr. Antonia on the Promise of Immunotherapy in NSCLC (OncLive)
Features Scott J. Antonia, MD, PhD

Genomic Testing Linked With Lower Health Care Costs in High-Risk Breast Cancer (Journal of Clinical Pathways)
Features Michaela Dinan, PhD

In TEDMED Talk, Kate Bowler Talks About Life Following Her Diagnosis With Stage 4 Cancer (Duke Today)

Drug makes tumors more susceptible to chemo (MIT)
Features Pei Zhou, PhD; Jiyong Hong, PhD; and Javaria Najeeb

A Molecular Glue to Overcome Cancer Drug Resistance? (Duke Today)
Features Pei Zhou, PhD

2019 Distinguished Faculty Award - Donald McDonnell, PhD (Duke University School of Medicine)

Francesca Rigiroli, MD, awarded a research fellowship promoted by the Bracco Foundation (Duke Radiology)
Features Francesca Rigiroli, MD

WATCH: 2019 Duke Health Emeriti Faculty Francis Ali-Osman, MD, FACS, DSc, Honored at Special Dinner  (Duke Medical Alumni)

Papers

(Duke affiliated researchers are bolded)

Policy Changes Key To Promoting Sustainability And Growth Of The Specialty Palliative Care Workforce. June 2019. Health Affairs. Arif H. Kamal, Steven P. Wolf, Jesse Troy, Victoria Leff, Constance Dahlin, Joseph D. Rotella, George Handzo, Phillip E. Rodgers, and Evan R. Myers.

CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. Nature Communications. June 4, 2019. Luigi Racioppi, Erik R. Nelson, Wei Huang, Debarati Mukherjee, Scott A. Lawrence, William Lento, Anna Maria Masci, Yiquin Jiao, Sunghee Park, Brian York, Yaping Liu, Amy E. Baek, David H. Drewry, William J. Zuercher, Francesca R. Bertani, Luca Businaro, Joseph Geradts, Allison Hall, Anthony R. Means, Nelson Chao, Ching-yi Chang & Donald P. McDonnell.

The importance of including diverse populations in cancer genomic and epigenomic studies. Nature Reviews Cancer. June 3, 2019. Bin Tean Teh, MD, PhD. (Duke NUS)

The effect of treatment on patient‐reported distress after breast cancer diagnosis. Cancer. May 23, 2019. Oluwadamilola M. Fayanju MD, MA, MPHS; Karine Yenokyan, MS, PhD; Yi Ren, MS; Benjamin A. Goldstein, PhD; Ilona Stashko, BS; Steve Power, MBA; Madeline J. Thornton, BA; P. Kelly Marcom, MD; E. Shelley Hwang MD, MPH.

Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects? Biology of Blood and Marrow Transplantation. May 7, 2019. JieWang; Ahmed Galal.